Back
Autolus Therapeutics PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
24
AUTL
Autolus Therapeutics PLC
Last Price:
3.48
Seasonality Move:
-14.93%
Sell
44
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.03
Seasonality Move:
-8.14%
Sell
24
Autolus Therapeutics PLC (AUTL)
is a Sell
Is Autolus Therapeutics PLC a Buy, Sell or Hold?
- The current Autolus Therapeutics PLC [AUTL] share price is $3.49. The Score for AUTL is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- AUTL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.02. The Score for ADAP is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AUTL Stock Price Chart
What is Autolus Therapeutics PLC's stock price today?
-
The Autolus Therapeutics PLC share price today is $3.49
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUTL is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.02
The current trend is relatively stagnant and ADAP is experiencing slight selling pressure.
AUTL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 38.55 | Sell |
| Chaikin Money Flow: | 487735 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.56 - 4.34) | Sell |
| Bollinger Bands (100): | (3.86 - 5.98) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 52.04 | Buy |
| Chaikin Money Flow: | -245892 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.91 - 1.07) | Buy |
| Bollinger Bands (100): | (0.99 - 1.45) | Sell |
AUTL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.47 | Buy |
| 20-day SMA: | 3.9 | Sell |
| 50-day SMA: | 3.99 | Sell |
| 200-day SMA: | 4.64 | Sell |
| 8-day EMA: | 3.53 | Sell |
| 20-day EMA: | 3.76 | Sell |
| 50-day EMA: | 4.13 | Sell |
| 200-day EMA: | 4.42 | Sell |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.96 | Buy |
| 20-day SMA: | 0.97 | Buy |
| 50-day SMA: | 1.06 | Sell |
| 200-day SMA: | 0.94 | Buy |
| 8-day EMA: | 0.99 | Buy |
| 20-day EMA: | 0.99 | Buy |
| 50-day EMA: | 1.05 | Sell |
| 200-day EMA: | 1.07 | Sell |
Autolus Therapeutics PLC Earnings Growth & AUTL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.02 per share, an increase this year of $0.29 per share, and an increase next year of $0.16 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.17 per share.
Autolus Therapeutics PLC Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||